AstraZeneca PLC (NYSE:AZN)
| 43.82 Delayed Data As of Apr 08 |  -0.03 / -0.07%Today’s Change | 36.15 Today|||52-Week Range 51.55 | -12.11% Year-to-Date |
Latest AZN News | Press Releases
| Should You Buy Inovio Pharmaceuticals During the Coronavirus Market Crash? Apr 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 43.85 |
| Today’s open | 43.43 |
| Day’s range | 42.84 - 44.10 |
| Volume | 8,499 |
| Average volume (3 months) | 3,981,672 |
| Market cap | $114.9B |
Data as of 3:59pm ET, 04/08/2020
Growth & Valuation
| Earnings growth (last year) | -39.32% |
| Earnings growth (this year) | +14.38% |
| Earnings growth (next 5 years) | +16.90% |
| Revenue growth (last year) | +16.27% |
| P/E ratio | 85.1 |
| Price/Sales | 5.06 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.58 | +1.30% |
| ABBVAbbVie | -0.04 | -0.05% |
| NVONovo Nordisk | +0.01 | +0.02% |
| BMYBristol-Myers Squibb | -0.02 | -0.03% |
Data as of 7:55pm ET, 04/08/2020
Financials
| Next reporting date | April 29, 2020 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $25.6B |
| Annual profit (last year) | $1.3B |
| Net profit margin | 5.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
